NO20090265L - Oral farmasoytisk sammensetning av en enkel vannloselig aktiv substans - Google Patents
Oral farmasoytisk sammensetning av en enkel vannloselig aktiv substansInfo
- Publication number
- NO20090265L NO20090265L NO20090265A NO20090265A NO20090265L NO 20090265 L NO20090265 L NO 20090265L NO 20090265 A NO20090265 A NO 20090265A NO 20090265 A NO20090265 A NO 20090265A NO 20090265 L NO20090265 L NO 20090265L
- Authority
- NO
- Norway
- Prior art keywords
- oral pharmaceutical
- soluble active
- pharmaceutical composition
- active substance
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81557906P | 2006-06-22 | 2006-06-22 | |
IN1473DE2006 | 2006-06-22 | ||
EP06115881 | 2006-06-22 | ||
PCT/EP2007/056207 WO2007147873A1 (en) | 2006-06-22 | 2007-06-21 | Oral pharmaceutical composition of a poorly water-soluble active substance |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090265L true NO20090265L (no) | 2009-01-22 |
Family
ID=38475974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090265A NO20090265L (no) | 2006-06-22 | 2009-01-16 | Oral farmasoytisk sammensetning av en enkel vannloselig aktiv substans |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2037890A1 (ja) |
JP (1) | JP2009541267A (ja) |
KR (1) | KR20090033246A (ja) |
AU (1) | AU2007263016A1 (ja) |
CA (1) | CA2654243A1 (ja) |
EA (1) | EA200970045A1 (ja) |
IL (1) | IL195653A0 (ja) |
NO (1) | NO20090265L (ja) |
WO (1) | WO2007147873A1 (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1397160A1 (en) * | 2001-04-30 | 2004-03-17 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
AR038681A1 (es) * | 2002-02-14 | 2005-01-26 | Solvay Pharm Bv | Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua |
WO2004062692A1 (en) * | 2003-01-13 | 2004-07-29 | Solvay Pharmaceuticals B.V. | Formulation of poorly water-soluble active substances |
TW200633713A (en) * | 2004-12-23 | 2006-10-01 | Solvay Pharm Bv | Oral immediate release formulation of a poorly water-soluble active substance |
WO2007054975A1 (en) * | 2005-11-08 | 2007-05-18 | Panacea Biotec Ltd | Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders |
-
2007
- 2007-06-21 WO PCT/EP2007/056207 patent/WO2007147873A1/en active Application Filing
- 2007-06-21 EP EP07730293A patent/EP2037890A1/en not_active Ceased
- 2007-06-21 AU AU2007263016A patent/AU2007263016A1/en not_active Abandoned
- 2007-06-21 EA EA200970045A patent/EA200970045A1/ru unknown
- 2007-06-21 KR KR1020097001506A patent/KR20090033246A/ko not_active Application Discontinuation
- 2007-06-21 CA CA002654243A patent/CA2654243A1/en not_active Abandoned
- 2007-06-21 JP JP2009515884A patent/JP2009541267A/ja not_active Withdrawn
-
2008
- 2008-12-02 IL IL195653A patent/IL195653A0/en unknown
-
2009
- 2009-01-16 NO NO20090265A patent/NO20090265L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2037890A1 (en) | 2009-03-25 |
WO2007147873A1 (en) | 2007-12-27 |
KR20090033246A (ko) | 2009-04-01 |
AU2007263016A1 (en) | 2007-12-27 |
EA200970045A1 (ru) | 2009-06-30 |
JP2009541267A (ja) | 2009-11-26 |
CA2654243A1 (en) | 2007-12-27 |
IL195653A0 (en) | 2009-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200572A (et) | Pertsükvinniin, selle valmistamismeetod, kandseene liik ja farmatseutiline kompositsioon | |
TNSN08018A1 (en) | Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor | |
WO2007131088A3 (en) | Oral rehydration compositions | |
NO20054974L (no) | 9-azabicyklo(3.3.1)non-6-en derivater med et heteroatom i 3-posisjonen som renin inhibitorer | |
GB0614353D0 (en) | Oral compositions, their preparation and use | |
RU2005115855A (ru) | Композиция трамадола продлонгированного высвобождением с 24-часовым действием | |
DK1073415T3 (da) | Gelerbare farmaceutiske sammensætninger | |
AU2002236830A1 (en) | Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors | |
AU2010224668A8 (en) | Wellbore servicing compositions comprising a set retarding agent and methods of making and using same | |
NZ597260A (en) | Formulations for parenteral delivery of compounds and uses thereof comprising methylnaltrexone | |
NO20062511L (no) | Fenoksy-eddiksyrederivater anvendelige som peroksisomproliferator-aktiverende reseptor (PPAR) dualagonister | |
ATE345041T1 (de) | Konzentrierte wasserlösliche granulatförmige pflanzenwachstumsregulatorformulierung und verfahren zu ihrer verwendung | |
NO341573B1 (no) | Faste formuleringer av ospemifen og fremgangsmåte for fremstilling av ospemifen | |
NO20082265L (no) | Dispergerbare tabletter som innbefatter deferasirox | |
NO20001521L (no) | Ikke-aerosolbasert gelblanding for barbering | |
CA2429639A1 (en) | Stable azithromycin monohydrate | |
NO20090265L (no) | Oral farmasoytisk sammensetning av en enkel vannloselig aktiv substans | |
AU2003255527A1 (en) | Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant | |
AU7532994A (en) | Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt | |
UA94275C2 (ru) | Фармацевтическая композиция, которая содержит по крайней мере один активный наркотический или психотропный компонент, назначенный способ введения которых в организм тяжело поддается изменению | |
WO2006033505A8 (en) | Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives | |
SE0103722D0 (sv) | Novel formulation | |
IS2446B (is) | Nýtt galenskt form til inngjafar um munn með hægri losun á molsidómíni. | |
AR061540A1 (es) | Composicion farmaceutica oral mejorada de un agente activo escasamente soluble en agua | |
AU2001273935A1 (en) | Method for the production of detergent granules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |